Trial Profile
Dietary Impacts on Glucose-lowering Effects of Sitagliptin in Type 2 Diabetes: a Multicenter, Randomized, Prospective, Open-label, Clinical Trial
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Jul 2019
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary) ; Glimepiride
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms DIET
- 30 Aug 2016 Status changed from recruiting to completed.
- 27 Apr 2015 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.
- 30 Mar 2015 Status changed from not yet recruiting to recruiting, according to to ClinicalTrials.gov record.